Aizen is an AI-driven biotech company developing Mirror Peptides, a new class of biologic medicines.
Aizen Therapeutic has raised $13.0M in total funding. The most recent round was Seed. The last funding was announced in November 2024.
Aizen Therapeutic's investors include Madrona, Cercano Management, Wilson Hill Ventures.
Aizen Therapeutic is headquartered in San Diego, United States.
Aizen is an AI-driven biotech company developing Mirror Peptides, a new class of biologic medicines.
Aizen Therapeutic is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aizen Therapeutic — Funding & Investors." VCBacked, November 21, 2024, https://www.vcbacked.co/company/aizen-therapeutic. Accessed July 22, 2026.
VCBacked. (2024). Aizen Therapeutic — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/aizen-therapeutic
{{cite web |title=Aizen Therapeutic — Funding & Investors |url=https://www.vcbacked.co/company/aizen-therapeutic |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated